Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Second-Line Ponatinib in Chronic Phase Chronic Myeloid Leukemia (CML-CP) Patients Failing or Intolerant to First-Line Second Generation Tyrosine Kinase Inhibitor (TKI) Treatment: An Interim Analysis of the Prospective PONS Trial

Philipp le Coutre, Joachim R Göthert, Susanne Saussele, Uwe Pelzer, Lars Bullinger, Ahmet Elmaagacli, Christian Jehn, Frank Stegelmann, Andreas Hochhaus, Thomas Ernst, Andreas Burchert

Blood (2022) 140 (Supplement 1): 12202–12203.

https://doi.org/10.1182/blood-2022-162281

Published: 2022

Journal Articles

A Novel Early Relapse Prediction Score Based on Age, ISS and Disease Status at the Time of Transplant in Patients with Newly Diagnosed Multiple Myeloma. a Study of the EBMT Chronic Malignancies Working Party

Blood (2021) 138 (Supplement 1): 3937.

https://doi.org/10.1182/blood-2021-147001

Published: 2021

Journal Articles

Allogeneic Stem Cell Transplantation in Patients Aged ≥70 Years: Epidemiology, Outcomes, and Risk Factors Based on the German Registry for Stem Cell Transplantation (DRST)

Blood (2021) 138 (Supplement 1): 3926.

https://doi.org/10.1182/blood-2021-152349

Published: 2021

Journal Articles

TP53 Status As Well As Cytogenetic Complexity Significantly Impact on Prognosis in Myelodysplastic Syndromes with Complex (≥3 anomalies) Aberrant Karyotypes

Blood (2019) 134 (Supplement_1): 3007.

https://doi.org/10.1182/blood-2019-126671

Published: 2019

Journal Articles

Comorbidities Are Frequent in Older Patients with De Novo Acute Lymphoblastic Leukemia (ALL) and Correlate with Induction Mortality: Analysis of More Than 1200 Patients from GMALL Data Bases

Blood (2018) 132 (Supplement 1): 660.

https://doi.org/10.1182/blood-2018-99-111954

Published: 2018

Journal Articles

Sorafenib As Maintenance Therapy Post Allogeneic Stem Cell Transplantation for FLT3-ITD Positive AML: Results from the Randomized, Double-Blind, Placebo-Controlled Multicentre Sormain Trial

Blood (2018) 132 (Supplement 1): 661.

https://doi.org/10.1182/blood-2018-99-112614

Published: 2018

Journal Articles

Molecular Profile and Cytomorphological Manifestation of Isolated Y Loss in Myelodysplastic Syndromes

Blood (2018) 132 (Supplement 1): 4358.

https://doi.org/10.1182/blood-2018-99-114216

Published: 2018

Journal Articles

Post-Transplant Cyclophosphamide (PT-Cy) for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Transplantation from HLA Identical Sibling and Matched Unrelated Donor for Patients with Acute Leukemia, on Behalf of ALWP-EBMT

Annalisa Ruggeri, MD, Myriam Labopin, MD, Boris V Afanasyev, MD PhD Professor, Jan J Cornelissen, Ahmet Elmaagacli, MD, Maija Itälä-Remes, MD PhD, Didier Blaise, Ellen Meijer, Koc Yener, Noel Milpied, Harry C. Schouten, MD, Nicolaus Kröger, Mohamad Mohty, MD PhD, Andrea Bacigalupo, MD, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 215.

https://doi.org/10.1182/blood.V130.Suppl_1.215.215

Published: 2017

Journal Articles

Response-Adapted Lenalidomide Maintenance in Newly Diagnosed, Transplant-Eligible Multiple Myeloma: Results from the Multicenter Phase III GMMG-MM5 Trial

Blood (2017) 130 (Supplement 1): 400.

https://doi.org/10.1182/blood.V130.Suppl_1.400.400

Published: 2017

Journal Articles

Results of Simultaneously Performed Analysis of 48 Gene Variants Reported to Have Influence on Transplant outcome

Ahmet Elmaagacli, MD, Michael Koldehoff, MD, Nina Steckel, Hellmut Ottinger, Dietrich Beelen

Blood (2011) 118 (21): 3047.

https://doi.org/10.1182/blood.V118.21.3047.3047

Published: 2011

Journal Articles

Inhibition of mTOR with Everolimus (RAD001) and Silencing by Vascular Endothelial Cell Growth Factor Specific siRNA Induces Additive Antitumor Activity in Multiple Myeloma Cells,

Michael Koldehoff, MD, Ahmet Elmaagacli, MD, Dietrich W. Beelen

Blood (2011) 118 (21): 3984.

https://doi.org/10.1182/blood.V118.21.3984.3984

Published: 2011

Journal Articles

Toll-Like-Receptor Expression and Cellular Immune Reconstitution In AML-Patients with Elevated Serum Ferritin Levels After Allogeneic transplant.

Ahmet Elmaagacli, Nina Steckel, Michael Koldehoff, MD, Sandra Christoph, Hellmut Ottinger, Rudolf Trenschel, Dietrich Beelen

Blood (2010) 116 (21): 1049.

https://doi.org/10.1182/blood.V116.21.1049.1049

Published: 2010

Journal Articles

Additive Effects of Anti-Leukemia Capacity by Gfi-1B- and Bcr-Abl-Specific siRNA In Advanced Chronic Myeloid Leukemic Cells

Michael Koldehoff, MD, Nina Steckel, Dietrich Beelen, Ahmet Elmaagacli

Blood (2010) 116 (21): 4466.

https://doi.org/10.1182/blood.V116.21.4466.4466

Published: 2010

Journal Articles

Treosulfan Compared to Total Body Irradiation-Based Preparative Regimens Before Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia : A Retrospective Long-Term Study.

Dietrich Wilhelm Beelen, MD, Tanja Gromke, MD, Rudolf Trenschel, MD, Inken Hilgendorf, MD, Daniel Wolff, MD, Ahmet Elmaagacli, MD, Mathias Freund, MD, Jochen Casper, MD

Blood (2008) 112 (11): 2149.

https://doi.org/10.1182/blood.V112.11.2149.2149

Published: 2008

Journal Articles

A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease

Mary E. D. Flowers, Jane F. Apperley, Koen van Besien, Ahmet Elmaagacli, Andrew Grigg, Vijay Reddy, Andrea Bacigalupo, Hans-Jochem Kolb, Luis Bouzas, Mauricette Michallet, H. Miles Prince, Robert Knobler, Dennis Parenti, Jose Gallo, Hildegard T. Greinix

Blood (2008) 112 (7): 2667–2674.

https://doi.org/10.1182/blood-2008-03-141481

Published: 2008

Includes: Supplemental data

Journal Articles

Adoptive Donor T-Cell Infusions Are Necessary and Efficient To Induce Lasting Molecular Remissions after Highly Purified CD34+ Sibling Donor Transplants for First Chronic Phase Chronic Myeloid Leukemia - Final Report and Long-Term Follow-Up of a Phase II Study.

Ahmet Elmaagacli, MD, Rudolf Peceny, M.D., Michael Koldehoff, M.D., Hellmut Ottinger, M.D., Rudolf Trenschel, M.D., Nina K. Steckel, M.D., Dietrich W. Beelen, M.D.

Blood (2006) 108 (11): 3017.

https://doi.org/10.1182/blood.V108.11.3017.3017

Published: 2006

Journal Articles

A Randomized Single−Blind Study of Extracorporeal Photopheresis with UVADEX® Plus Conventional Therapy (CT) Compared to CT Alone in Chronic GVHD.

Mary E.D. Flowers, MD, Koen Van Besien, MD, Jane Apperley, MD, Andrea Bacigalupo, MD, Ahmet Elmaagacli, MD, Andrew Grigg, MD, Hans-Jochem Kolb, MD, Luis Fernando Bouzas, MD, Mauricette Michallet, MD, Vijay Reddy, MD, Jim Wang, MD, Paul Williamson, MD, Robert Knobler, MD, Hildegard Greinix, MD

Blood (2006) 108 (11): 758.

https://doi.org/10.1182/blood.V108.11.758.758

Published: 2006

Journal Articles

Myeloablative Treosulfan as Preparative Regimen for Allogeneic Haematopoietic Stem Cell Transplantation: A Single-Centre Experience.

Rudolf Trenschel, MD, Markus Ditschkowski, MD, Ahmet Elmaagacli, MD, Nina K. Steckel, MD, Michal Hlinka, MD, Rudolf Peceny, MD, Helmut Ottinger, MD, Michael Koldehoff, MD, Harry Biersack, MD, Michael Flasshove, MD, Dietrich W. Beelen, MD

Blood (2004) 104 (11): 3343.

https://doi.org/10.1182/blood.V104.11.3343.3343

Published: 2004

Journal Articles

Influence of Pretreatment with Amphotericin B on Treatement-Related Mortality (TRM) Following Allogeneic Stem Cell Transplantations.

Rudolf Trenschel, MD, Markus Ditschkowski, MD, Nina K. Steckel, MD, Michal Hlinka, MD, Ahmet Elmaagacli, MD, Helmut Ottinger, MD, Micheal Flasshove, MD, Dietrich W. Beelen, MD

Blood (2004) 104 (11): 5049.

https://doi.org/10.1182/blood.V104.11.5049.5049

Published: 2004

Journal Articles

Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose

Cesare Guglielmi, William Arcese, Francesco Dazzi, Ronald Brand, Donald Bunjes, Leo F. Verdonck, Anton Schattenberg, Hans-Jochem Kolb, Per Ljungman, Agnes Devergie, Andrea Bacigalupo, Marta Gomez, Mauricette Michallet, Ahmet Elmaagacli, Alois Gratwohl, Jane Apperley, Dietger Niederwieser

Blood (2002) 100 (2): 397–405.

https://doi.org/10.1182/blood.V100.2.397

Published: 2002

NARROW

Second-Line Ponatinib in Chronic Phase Chronic Myeloid Leukemia (CML-CP) Patients Failing or Intolerant to First-Line Second Generation Tyrosine Kinase Inhibitor (TKI) Treatment: An Interim Analysis of the Prospective PONS Trial

A Novel Early Relapse Prediction Score Based on Age, ISS and Disease Status at the Time of Transplant in Patients with Newly Diagnosed Multiple Myeloma. a Study of the EBMT Chronic Malignancies Working Party

Allogeneic Stem Cell Transplantation in Patients Aged ≥70 Years: Epidemiology, Outcomes, and Risk Factors Based on the German Registry for Stem Cell Transplantation (DRST)

TP53 Status As Well As Cytogenetic Complexity Significantly Impact on Prognosis in Myelodysplastic Syndromes with Complex (≥3 anomalies) Aberrant Karyotypes

Comorbidities Are Frequent in Older Patients with De Novo Acute Lymphoblastic Leukemia (ALL) and Correlate with Induction Mortality: Analysis of More Than 1200 Patients from GMALL Data Bases

Sorafenib As Maintenance Therapy Post Allogeneic Stem Cell Transplantation for FLT3-ITD Positive AML: Results from the Randomized, Double-Blind, Placebo-Controlled Multicentre Sormain Trial

Molecular Profile and Cytomorphological Manifestation of Isolated Y Loss in Myelodysplastic Syndromes

Post-Transplant Cyclophosphamide (PT-Cy) for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Transplantation from HLA Identical Sibling and Matched Unrelated Donor for Patients with Acute Leukemia, on Behalf of ALWP-EBMT

Response-Adapted Lenalidomide Maintenance in Newly Diagnosed, Transplant-Eligible Multiple Myeloma: Results from the Multicenter Phase III GMMG-MM5 Trial

Results of Simultaneously Performed Analysis of 48 Gene Variants Reported to Have Influence on Transplant outcome

Inhibition of mTOR with Everolimus (RAD001) and Silencing by Vascular Endothelial Cell Growth Factor Specific siRNA Induces Additive Antitumor Activity in Multiple Myeloma Cells,

Toll-Like-Receptor Expression and Cellular Immune Reconstitution In AML-Patients with Elevated Serum Ferritin Levels After Allogeneic transplant.

Additive Effects of Anti-Leukemia Capacity by Gfi-1B- and Bcr-Abl-Specific siRNA In Advanced Chronic Myeloid Leukemic Cells

Treosulfan Compared to Total Body Irradiation-Based Preparative Regimens Before Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia : A Retrospective Long-Term Study.

A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease

Adoptive Donor T-Cell Infusions Are Necessary and Efficient To Induce Lasting Molecular Remissions after Highly Purified CD34+ Sibling Donor Transplants for First Chronic Phase Chronic Myeloid Leukemia - Final Report and Long-Term Follow-Up of a Phase II Study.

A Randomized Single−Blind Study of Extracorporeal Photopheresis with UVADEX® Plus Conventional Therapy (CT) Compared to CT Alone in Chronic GVHD.

Myeloablative Treosulfan as Preparative Regimen for Allogeneic Haematopoietic Stem Cell Transplantation: A Single-Centre Experience.

Influence of Pretreatment with Amphotericin B on Treatement-Related Mortality (TRM) Following Allogeneic Stem Cell Transplantations.

Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only